NFI Consumer Healthcare, a division of Gregory Pharmaceutical Holdings, has entered into a definitive acquisition agreement under which NFI has acquired the worldwide rights to the OTC brand e.p.t.
e.p.t® is the preeminent pregnancy test kit brand with a leading brand equity franchise. The brand established the category in 1977 when it introduced the first OTC home pregnancy test kit in North America, and has since been successfully used by millions of women. The test kits are marketed in both analog and digital formats and are broadly distributed through the drug, mass, and food distribution channels.
"We are extremely excited to be entering the women's health OTC market with the acquisition of e.p.t® and embarking upon the next avenue of growth for our OTC business. NFI will build upon the sales and marketing efforts for e.p.t® and continue to focus on its expansion into existing and new market channels as we have done with Blue Emu which has grown over 300% during the 3 years of our ownership," said Susan Gregory, CEO of NFI.
Mr. Ron Lombardi, CEO of Prestige Brands Holdings stated, "This divesture was a successful outcome as it enabled both Companies to move closer to their longer-term goals. NFI is well respected in the consumer healthcare channel and we believe this brand will be a strong addition to their portfolio."